Table 5.
Symbol | Gene name | Degree | Relevant function | Reference |
---|---|---|---|---|
ITGAM | integrin subunit alpha M | 78 | A poor prognostic factor in MM and AML patients; | 57-61 |
MMP9 | Matrix metallopeptidase 9 | 64 | Participates in the breakdown of extracellular matrix; Promotes invasion of MM; | 73, 79-84 |
ITGB2 | Integrin subunit beta 2 | 62 | Involved in cell adhesion and cell-surface mediated signaling; Associated with drug resistance to chemotherapy in MM cell line; |
63, 66 |
FPR2 | Formyl-peptide receptor-2 | 52 | Associated with invasion and metastasis of some cancers; | 96-98 |
C3AR1 | complement C3a receptor 1 | 51 | Involved in drug resistance to chemotherapy in AML cell; Predicts overall survival of AML; |
99 |
CXCL1 | C-X-C motif chemokine ligand 1 | 51 | Associated with the growth and progression of some cancers; | 100-102 |
CYBB | cytochrome b-245 beta chain | 48 | Involved in the progression of some cancers by promotion of angiogenesis; | 103, 104 |
LILRB2 | leukocyte immunoglobulin like receptor B2 | 46 | Inhibits stimulation of an immune response; Promotes tumor progression; | 105-107 |
HP | haptoglobin | 44 | NA | - |
FCER1G | Fc fragment of IgE receptor Ig | 43 | Associated with disease progression in lymphoma and some solid cancers; Deficient expression represents T-cell immunodeficiency in CLL. |
108-110 |